Navigation Links
Promising Data on Cognitive Effects of Safinamide in Early,Parkinson's Disease

day dose-range based on UPDRS scoring.

The cognition component of the trial was a secondary endpoint and was carried out in selected centers, equipped to perform this type of assessment.
2 Strategic Target Detection Test (complex attention, executive function): This test requires the subject to touch the target stimuli (shapes) directly of a touch screen. The participant must learn which target is correct by choosing one of the stimuli following computer-generated feedback.
3 Auditory Number Sequencing (attention, working memory, executive function): Subjects hear a series of numbers (e.g. “9.. 3.. 6“; minimum=2 digits, maximum=8 digits) and are asked to repeat the numbers in order, from lowest to highest, requiring both working memory maintenance and manipulation.

About safinamide
Safinamide is an alpha-aminoamide derivative which is orally administered. Safinamide is believed to have a novel mode of action as a dopamine modulator (comprising both selective and reversible MAO-B inhibition and also blockade of dopamine reuptake) complemented by an effect on the glutamate pathway. Studies suggest that safinamide may combine the inhibition of dopamine re-uptake and MAO-B, two key mechanisms involved in the control of dopamine concentration in the brain, and inhibition of glutamate release. If regulatory approvals are obtained, Merck Serono and Newron believe that safinamide, as an adjunctive treatment to dopamine agonists and levodopa, may have a competitive advantage over current therapies for Parkinson’s disease.

About Parkinson’s disease
Parkinson's disease is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
5. Antisense Pharma: Promising Phase IIb Results of Targeted Therapy with AP 12009 in Recurrent Anaplastic Astrocytoma
6. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
7. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
8. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
9. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
10. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
11. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
Post Your Comments:
(Date:4/17/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of cancer and diseases of ... data from three of its most advanced oncology programs ... 106 th Annual Meeting being held from April ... USA. The presentation on the BNC105 ...
(Date:4/16/2015)... April 16, 2015 Vanda Pharmaceuticals Inc. (Vanda) ... the development and commercialization of products for the treatment ... release results for the first quarter of 2015 on ... The Company will host a conference call ... during which Vanda management will discuss the first quarter ...
(Date:4/16/2015)... 16, 2015 A drug commonly taken to prevent ... with multiple sclerosis (MS), according to a study released today ... 67th Annual Meeting in Washington, DC , ... of people with MS experience at some point in their ... nerve carrying vision from the eye to the brain gets ...
Breaking Medicine Technology:Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Epilepsy Drug May Preserve Eyesight for People with MS 2
... Calif., Nov. 5 Bionovo, Inc. (Nasdaq: BNVI ... the unmet needs in women,s health and oncology, today ... three months ended September 30, 2009. , Subsequent to ... successfully completed a public offering and issued approximately 31 ...
... , SAN DIEGO, Nov. 5, 2009 Amylin Pharmaceuticals, Inc. ... Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, ... ET. Mark Foletta, senior vice president of finance and ... corporate overview. , The audio portion of the presentation will ...
Cached Medicine Technology:Bionovo Announces Third Quarter 2009 Highlights and Financial Results 2Bionovo Announces Third Quarter 2009 Highlights and Financial Results 3Bionovo Announces Third Quarter 2009 Highlights and Financial Results 4Bionovo Announces Third Quarter 2009 Highlights and Financial Results 5Bionovo Announces Third Quarter 2009 Highlights and Financial Results 6Bionovo Announces Third Quarter 2009 Highlights and Financial Results 7Bionovo Announces Third Quarter 2009 Highlights and Financial Results 8Bionovo Announces Third Quarter 2009 Highlights and Financial Results 9
(Date:4/18/2015)... 18, 2015 Carinsurancequotesinfo.com has released a ... cover physical injuries caused by a car accident. ... coverage for a vehicle. A policy can pay for ... accident. Drivers should always carry appropriate coverage when they ... can be bought with several important riders that offer ...
(Date:4/18/2015)... "I wanted to live a ... healthful juice that contained essential vitamins, minerals and ... increases my energy, improves skin elasticity and gives ... Tapp's Juice to contain fruits, vegetables and other ... and mental fatigue. It features a great taste. ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Lower-auto-insurance.com has ... accurate auto insurance quotes . , ... policies by comparing quotes. A professional insurance brokerage website ... insurance quotes, in a simple, convenient way. The whole ... to anyone. , Comparing online car insurance quotes ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 More than ... sale now at TheCelebrityDresses.com, the #1 online store carrying ... ongoing many girls have got their perfect dresses for ... the celebrity fashion prom dresses at TheCelebrityDresses.com would be ... designed more than 2000 prom dresses inspired by the ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 PHOENIX, ARIZONA ... County, along with 11 other secure destruction professionals across ... Destruction Specialists (CSDS). He will now display “CSDS” as ... were offered before the National Association of Information Destruction ... and another Grapevine, Texas. Of the 20 people who ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... Calif., May 7 The CPF today announced that the ... would authorize $16 million in new federal funding for pulmonary ... 27 Members of the U.S. House of Representatives. The ... and awareness of pulmonary fibrosis, a terminal lung disease with ...
... HMSY ) today announced that it will present ... Conference, which will be held Tuesday, May 12 ... City. The Company will present on Tuesday, May 12th at ... be accessed through our website at http://www.hms.com/investor_relations/investors_presentations.asp ...
... Conseco, Inc. (NYSE: CNO ) today responded ... subscribers who hold Conseco, Inc. stock vote for eight ... dissident nominee for the ninth director up for election."RMG ... to elect a dissident at Conseco,s upcoming annual meeting ...
... Facial Surgery in a Live Case Study for TWTRCON ... TWTRCON SF 09, the first conference focused on ... Operation Smile would be launching a groundbreaking new fundraising ... creating a live case study in which TWTRCON attendees ...
... May 7 /PRNewswire/ - Axela Inc., is pleased to ... dotLab(R) System that provides technical controls to support compliance ... will be of particular interest to those working in ... secure database, audit trails, electronic signature controls and user ...
... the U.S. once again a resounding successNEW YORK, May ... friends and supporters, joined the more than 10,000 people ... April 25th to celebrate the 15th Parkinson,s Unity Walk ... Parkinson,s disease research.This year marked an incredible year for ...
Cached Medicine News:Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 2Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 3Health News:Co-Sponsorship of Pulmonary Fibrosis Research Enhancement Act 2009 Increases to 27 Members 4Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 2Health News:Operation Smile To Launch Groundbreaking 140 Smiles Fundraising Campaign at TWTRCON SF 09 3Health News:Axela introduces software to support 21 CFR Part 11 Compliance for Regulated Environments 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 2Health News:15th Parkinson's Unity Walk A Step in the Right Direction for Parkinson's Community 3
P-Series Cystourethroscope Short Bridge, examining...
Short single-horn bridge for insertion of instruments...
Albarran double-horn bridge for use with sheaths from 20-25 Fr and designed for accurate articulation of flexible devices....
Designed for accurate articulation of flexible devices....
Medicine Products: